01 ATAZANAVIR SULFATE (4)
01 BRISTOL MYERS SQUIBB (4)
01 CAPSULE;ORAL (4)
01 EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
03 EQ 200MG BASE (1)
04 EQ 300MG BASE (1)
01 USA (4)
19
Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATAZANAVIR SULFATE, with a corresponding application number 21567 and regulatory information .
proudly manufactured in the
approval since 2003-06-20
Bristol Myers Squibb's REYATAZ CAPSULE;ORAL, medication with EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ATAZANAVIR SULFATE.
18
Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATAZANAVIR SULFATE, with a corresponding application number 21567 and regulatory information .
proudly manufactured in the
approval since 2003-06-20
Bristol Myers Squibb's REYATAZ CAPSULE;ORAL, medication with EQ 200MG BASE of ATAZANAVIR SULFATE.
17
Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATAZANAVIR SULFATE, with a corresponding application number 21567 and regulatory information .
proudly manufactured in the
approval since 2003-06-20
Bristol Myers Squibb's REYATAZ CAPSULE;ORAL, medication with EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ATAZANAVIR SULFATE.
16
Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATAZANAVIR SULFATE, with a corresponding application number 21567 and regulatory information .
proudly manufactured in the
approval since 2006-10-16
Bristol Myers Squibb's REYATAZ CAPSULE;ORAL, medication with EQ 300MG BASE of ATAZANAVIR SULFATE.